A Comparison of the Therapeutic Plan Costs in the Treatment of HIV-Positive Patients (Q57004633)

article

Language	Label	Description	Also known as
English	A Comparison of the Therapeutic Plan Costs in the Treatment of HIV-Positive Patients	article

Statements

instance of

scholarly article

0 references

title

A Comparison of the Therapeutic Plan Costs in the Treatment of HIV-Positive Patients (English)

0 references

author name string

S Sabbatani

series ordinal

1

0 references

language of work or name

English

0 references

publication date

2003

0 references

published in

Clinical Drug Investigation

0 references

volume

23

0 references

issue

7

0 references

page(s)

473-8

0 references

cites work

Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17535058

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17535058

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modeling the Long-Term Outcomes and Costs of HIV Antiretroviral Therapy Using HIV RNA Levels: Application to a Clinical Trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17535058

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modeling the use of triple combination therapy in five countries: nevirapine, Zidovudine, and Didanosine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17535058

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17535058

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17535058

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17535058

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The private costs of HIV/AIDS.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17535058

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17535058

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17535058

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17535058

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination antiretroviral therapy in HIV infection. An economic perspective

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17535058

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00044011-200323070-00006

0 references

PubMed publication ID

17535058

0 references

A Comparison of the Therapeutic Plan Costs in the Treatment of HIV-Positive Patients (Q57004633)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

A Comparison of the Therapeutic Plan Costs in the Treatment of HIV-Positive Patients (Q57004633)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search